Preparing Transplant, Cellular Therapy Recipients for the Respiratory Viral Season

The 2025-2026 respiratory viral season is approaching. With it comes the familiar challenge of protecting our most vulnerable patients — those who have undergone hematopoietic cell transplantation or received chimeric antigen receptor T-cell therapy. As clinicians, we are not only tasked with managing immunocompromised hosts through these infections but also with navigating evolving vaccine recommendations and community trends.

Read the full article on Healio.